GLP-1 receptor agonists: panacea or affirmation of societal failure?
British Journal of General Practice · 2025-04 · 75 (753) · 148-149
DOI: 10.3399/bjgp25x741069 ↗Kurz gefasst
Editorial in der Zeitschrift British Journal of General Practice, online erschienen am 27.03.2025. Verfasst von Tomazo J Kallis und 1 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Pharmacist, Clinical Research Fellow; Health and Community Sciences, University of Exeter, Exeter. Die Arbeit nennt 13 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Clinical Pharmacist, Clinical Research Fellow; Health and Community Sciences, University of Exeter, Exeter.
- Professor of Primary Care and Clinical Pharmacology; Health and Community Sciences, University of Exeter, Exeter.
Zitieren
APA
Kallis, T. J., & Payne, R. A. (2025). GLP-1 receptor agonists: panacea or affirmation of societal failure?. British Journal of General Practice, 75(753), 148-149. https://doi.org/10.3399/bjgp25x741069
Vancouver
Kallis TJ, Payne RA. GLP-1 receptor agonists: panacea or affirmation of societal failure?. British Journal of General Practice. 2025;75(753):148-149. doi:10.3399/bjgp25x741069
BibTeX
@article{Kallis2025,
author = {Kallis, Tomazo J and Payne, Rupert A},
title = {GLP-1 receptor agonists: panacea or affirmation of societal failure?},
journal = {British Journal of General Practice},
year = {2025},
volume = {75},
number = {753},
pages = {148--149},
doi = {10.3399/bjgp25x741069}
}
EUVIMED